Public Profile

VIVUS, Inc.

VIVUS, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States and focuses on developing innovative therapies for obesity and sexual health. Founded in 1991, the company has achieved significant milestones, including the launch of its flagship product, Qsymia, which addresses obesity management through a unique combination of active ingredients. With a commitment to advancing patient care, VIVUS also offers the erectile dysfunction treatment, Stendra, which stands out for its rapid onset of action. The company has established a strong market position, recognised for its dedication to research and development in niche therapeutic areas. VIVUS continues to strive for excellence, aiming to improve the quality of life for patients through its specialised products and services.

DitchCarbon Score

How does VIVUS, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

VIVUS, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

VIVUS, Inc.'s reported carbon emissions

VIVUS, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for recent years, as indicated by the absence of specific emissions figures. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In terms of climate commitments, VIVUS has not outlined any specific reduction targets or initiatives in the provided information. This lack of data suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its commitments. As the industry increasingly prioritises sustainability and carbon reduction, VIVUS may need to consider establishing measurable targets and reporting frameworks to align with best practices in climate accountability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. VIVUS, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for VIVUS, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

VIVUS, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Laboratoires Servier

FR
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Astra Zeneca

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Genentech

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Eli Lilly and Company

GB
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Novo Nordisk A Slash S

DK
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers